news_6

China Non-Invasive Prenatal Testing Market Report 2022: Size, Trends, Share, Growth, Opportunity, and Forecasts 2018-2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Non-Invasive Prenatal Testing Market Size, Trends, Share, Growth, Opportunity, and Forecast 2022 - 2028" report has been...

news_6

Philippines Embedded Finance Markets Report 20222-2029: 50+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Philippines Embedded Finance Business and Investment Opportunities Databook - 50+ KPIs on Embedded Lending, Insurance, Payment, and Wealth...

news_6

Australia Embedded Finance Markets and Investment Opportunities Report 2022: Market is Expected to Grow by 46.4% to Reach $3,853.2 Million in 2022 – Forecast to 2029 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia Embedded Finance Business and Investment Opportunities Databook - 50+ KPIs on Embedded Lending, Insurance, Payment, and Wealth...

news_6

Alliance Healthcare’s Digital Healthcare Subsidiary, Jaga-Me, Received Positive Feedback for the Services Rendered to Patients on the National Cancer Centre Singapore’s Home Care Programme

news_6

Fujirebio enters the field of fully automated blood-based Alzheimer’s disease biomarker testing with the release of the Lumipulse® G pTau 181 Plasma assay for Research Use Only

GENT, Belgium & MALVERN, Pa. & TOKYO--(BUSINESS WIRE)--#IVD--H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability...